Antibodies to sclerostin or G-CSF receptor partially eliminate bone or marrow adipocyte loss, respectively, following vertical sleeve gastrectomy-Reference-Cited by-同舟云学术

Antibodies to sclerostin or G-CSF receptor partially eliminate bone or marrow adipocyte loss, respectively, following vertical sleeve gastrectomy

Published:2023-04 Issue: Volume:169 Page:116682
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Li Ziru,Qiu Kevin,Zhao Jingtong,Granger Katrina,Yu Hui,Lewis Alfor G.,Myronovych Andriy,Toure Mouhamadoul H.,Hatsell Sarah J.,Economides Aris N.,Seeley Randy J.,MacDougald Ormond A.

Funder

Michigan Nutrition Obesity Research Center, Medical School, University of Michigan

National Institutes of Health

American Diabetes Association

Regeneron Pharmaceuticals

Michigan Diabetes Research Center, University of Michigan

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference42 articles.

1. Bariatric surgery for obesity;le Roux;Med. Clin. N. Am.,2018

2. The role of GLP-1 in the metabolic success of bariatric surgery;Hutch;Endocrinology,2017

3. Metabolic surgery for the treatment of type 2 diabetes in obese individuals;Cummings;Diabetologia,2018

4. A meta-analysis of the effects of bariatric surgery on fracture risk;Zhang;Obes. Rev.,2018

5. Bone loss after bariatric surgery: causes, consequences, and management;Stein;Lancet Diabetes Endocrinol.,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of sclerostin in lipid and glucose metabolism disorders;Biochemical Pharmacology;2023-09

2. Obesity and myeloma: Clinical and mechanistic contributions to disease progression;Frontiers in Endocrinology;2023-02-23